MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Annovis Bio, Inc. (ANVS)

Annovis Bio, Inc. (ANVS)

|||

Balance Sheets Overview

Cash Ratio
294.54%
Debt to Asset Ratio
119.31%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Warrant liability
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
18,728,945
14,219,081
19,532,338
15,286,399
Prepaid expenses and other current assets
3,308,146
2,024,622
1,549,287
1,902,562
Total assets
22,037,091
16,243,703
21,081,625
17,188,961
Accounts payable
3,327,138
5,275,668
2,590,516
2,112,026
Accrued expenses
3,031,571
7,514,977
1,044,859
1,621,771
Total current liabilities
6,358,709
12,790,645
3,635,375
3,733,797
Warrant liability
19,933,000
327,000
595,000
299,000
Total liabilities
26,291,709
13,117,645
4,230,375
4,032,797
Common stock - 0.0001 par value, 70,000,000 shares authorized, 42,606,152 and 27,199,139 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
4,260
2,854
2,719
2,019
Additional paid-in capital
191,871,978
184,433,245
180,552,190
167,023,392
Accumulated deficit
-196,130,856
-181,310,041
-163,703,659
-153,869,247
Total stockholders' equity
-4,254,618
3,126,058
16,851,250
13,156,164
Total liabilities and stockholders' equity
22,037,091
16,243,703
21,081,625
17,188,961
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$18,728,945 (9.33%↑ Y/Y)Prepaid expenses andother current assets$3,308,146 (-23.50%↓ Y/Y)Total assets$22,037,091 (2.72%↑ Y/Y)Accumulated deficit-$196,130,856 (-33.78%↓ Y/Y)Total liabilities andstockholders' equity$22,037,091 (2.72%↑ Y/Y)Total stockholders'equity-$4,254,618 (-123.21%↓ Y/Y)Additional paid-in capital$191,871,978 (16.33%↑ Y/Y)Common stock - 0.0001par value,...$4,260 (118.69%↑ Y/Y)Total liabilities$26,291,709 (741.57%↑ Y/Y)Warrant liability$19,933,000 (6148.59%↑ Y/Y)Total currentliabilities$6,358,709 (126.68%↑ Y/Y)Accounts payable$3,327,138 (241.49%↑ Y/Y)Accrued expenses$3,031,571 (65.59%↑ Y/Y)